Cyclin D1 and Ovarian Tumors
Author Information
Author(s): F Barbieri, M Cagnoli, N Ragni, F Pedull, G Foglia, A Alama
Primary Institution: Istituto Nazionale Ricerca sul Cancro, University of Genoa
Hypothesis
The study investigates the expression of cyclin D1 in human ovarian lesions and its relationship with transformed phenotype and tumor kinetics.
Conclusion
Cyclin D1 expression is associated with the degree of malignancy in ovarian tumors.
Supporting Evidence
- Cyclin D1 protein levels were undetectable in benign tumors and elevated in malignant tumors.
- A significant relationship was found between cyclin D1 expression and tumor proliferative activity.
- Thymidine labeling index (TLI) values were lower in benign lesions compared to malignant ones.
Takeaway
This study found that cyclin D1 levels are low in benign ovarian tumors but high in malignant ones, suggesting it could help identify cancer severity.
Methodology
The study analyzed cyclin D1 protein and mRNA levels in ovarian tumor samples using Western blotting and RT-PCR.
Limitations
The study is based on a relatively small sample size and may not represent all ovarian tumors.
Participant Demographics
Patients included 10 with benign lesions, 5 with borderline tumors, and 18 with malignant ovarian disease.
Statistical Information
P-Value
0.0001; 0.0238; 0.000001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website